Cargando…

DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most devastating cancer types despite the improvement of modern medicine. In our present study, we found that dickkopf-related protein 2 (DKK2) shares a higher expression in PDAC compared with adjacent pancreas tissue in tissue microarray. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jianyu, Jiang, Yongsheng, He, Ruizhe, Liu, Wei, Yang, Minwei, Tao, Lingye, Fu, Xueliang, Shen, Yang, Li, Jiao, Liu, Dejun, Huo, Yanmiao, Zhang, Junfeng, Hua, Rong, Zhang, Zhigang, Sun, Yongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754880/
https://www.ncbi.nlm.nih.gov/pubmed/31583260
http://dx.doi.org/10.1155/2019/8656282
_version_ 1783453130684366848
author Yang, Jianyu
Jiang, Yongsheng
He, Ruizhe
Liu, Wei
Yang, Minwei
Tao, Lingye
Fu, Xueliang
Shen, Yang
Li, Jiao
Liu, Dejun
Huo, Yanmiao
Zhang, Junfeng
Hua, Rong
Zhang, Zhigang
Sun, Yongwei
author_facet Yang, Jianyu
Jiang, Yongsheng
He, Ruizhe
Liu, Wei
Yang, Minwei
Tao, Lingye
Fu, Xueliang
Shen, Yang
Li, Jiao
Liu, Dejun
Huo, Yanmiao
Zhang, Junfeng
Hua, Rong
Zhang, Zhigang
Sun, Yongwei
author_sort Yang, Jianyu
collection PubMed
description Pancreatic ductal adenocarcinoma (PDAC) remains one of the most devastating cancer types despite the improvement of modern medicine. In our present study, we found that dickkopf-related protein 2 (DKK2) shares a higher expression in PDAC compared with adjacent pancreas tissue in tissue microarray. In addition, an elevated expression of DKK2 predicts poorer prognosis of patients and positively correlated with poor tumor differentiation. Multivariate Cox regression analysis was also performed and confirmed that the expression of DKK2 is an independent prognostic factor in PDAC. A high expression of DKK2 correlates with cell migration and epithelial mesenchymal transition based on gene set enrichment analysis (GSEA) while knockdown of DKK2 in PDAC cells resulted in impaired cellular migration. Furthermore, GSEA predicts negative correlation between tumor immunity invasion and DKK2 expression. We then confirmed these results and demonstrated that a higher expression of DKK2 imparts the recruitment of CD8(+) T cells. Our work suggested that DKK2 imparts tumor immune evasion and is associated with poor prognosis in pancreatic ductal adenocarcinoma.
format Online
Article
Text
id pubmed-6754880
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67548802019-10-03 DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Yang, Jianyu Jiang, Yongsheng He, Ruizhe Liu, Wei Yang, Minwei Tao, Lingye Fu, Xueliang Shen, Yang Li, Jiao Liu, Dejun Huo, Yanmiao Zhang, Junfeng Hua, Rong Zhang, Zhigang Sun, Yongwei J Immunol Res Research Article Pancreatic ductal adenocarcinoma (PDAC) remains one of the most devastating cancer types despite the improvement of modern medicine. In our present study, we found that dickkopf-related protein 2 (DKK2) shares a higher expression in PDAC compared with adjacent pancreas tissue in tissue microarray. In addition, an elevated expression of DKK2 predicts poorer prognosis of patients and positively correlated with poor tumor differentiation. Multivariate Cox regression analysis was also performed and confirmed that the expression of DKK2 is an independent prognostic factor in PDAC. A high expression of DKK2 correlates with cell migration and epithelial mesenchymal transition based on gene set enrichment analysis (GSEA) while knockdown of DKK2 in PDAC cells resulted in impaired cellular migration. Furthermore, GSEA predicts negative correlation between tumor immunity invasion and DKK2 expression. We then confirmed these results and demonstrated that a higher expression of DKK2 imparts the recruitment of CD8(+) T cells. Our work suggested that DKK2 imparts tumor immune evasion and is associated with poor prognosis in pancreatic ductal adenocarcinoma. Hindawi 2019-09-08 /pmc/articles/PMC6754880/ /pubmed/31583260 http://dx.doi.org/10.1155/2019/8656282 Text en Copyright © 2019 Jianyu Yang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yang, Jianyu
Jiang, Yongsheng
He, Ruizhe
Liu, Wei
Yang, Minwei
Tao, Lingye
Fu, Xueliang
Shen, Yang
Li, Jiao
Liu, Dejun
Huo, Yanmiao
Zhang, Junfeng
Hua, Rong
Zhang, Zhigang
Sun, Yongwei
DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
title DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
title_full DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
title_fullStr DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
title_full_unstemmed DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
title_short DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
title_sort dkk2 impairs tumor immunity infiltration and correlates with poor prognosis in pancreatic ductal adenocarcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754880/
https://www.ncbi.nlm.nih.gov/pubmed/31583260
http://dx.doi.org/10.1155/2019/8656282
work_keys_str_mv AT yangjianyu dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT jiangyongsheng dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT heruizhe dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT liuwei dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT yangminwei dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT taolingye dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT fuxueliang dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT shenyang dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT lijiao dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT liudejun dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT huoyanmiao dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT zhangjunfeng dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT huarong dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT zhangzhigang dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma
AT sunyongwei dkk2impairstumorimmunityinfiltrationandcorrelateswithpoorprognosisinpancreaticductaladenocarcinoma